Page last updated: 2024-12-05

2-methylvaleric acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

2-methylvaleric acid : A methyl-branched fatty acid that is pentanoic acid which carries a methyl group at position 2. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID7341
CHEMBL ID1204680
CHEBI ID167644
SCHEMBL ID148477
MeSH IDM0104214

Synonyms (71)

Synonym
LS-13176
2-methyl-n-valeric acid
CHEBI:167644
fema 2754
nsc8406
.alpha.-methylvaleric acid
nsc-8406
methylpropylacetic acid
wln: qvy3 & 1
97-61-0
2-methylpentanoic acid
valeric acid, 2-methyl-
2-pentanecarboxylic acid
pentanoic acid, 2-methyl-
2-methylvaleric acid
nsc 8406
fema no. 2754
brn 1720655
alpha-methylvaleric acid
kyselina 2-methylvalerova [czech]
ai3-26042
einecs 202-594-9
2-methylpentanoic acid, >=98%, fcc, fg
2-methyl-pentanoic acid
2-methyl valeric acid
LMFA01020074
2-methylvaleric acid, 98%
M0610
(2s)-2-methylpentanoate
AKOS000120958
A845729
NCGC00248880-01
cas-97-61-0
dtxcid401633
tox21_200935
NCGC00258489-01
dtxsid9021633 ,
CHEMBL1204680
S3314
kyselina 2-methylvalerova
unii-26a19cg6j9
4-02-00-00942 (beilstein handbook reference)
ec 202-594-9
26a19cg6j9 ,
FT-0613070
27936-41-0
pentanoic acid, methyl-
SCHEMBL148477
(+-)-2-methylpentanoic acid
2-methylvaleric acid [fhfi]
dl-2-methylpentanoic acid
2-methylpentanoic acid [fcc]
valproic acid impurity l [ep impurity]
racemic 2-methylvaleric acid
AKOS016843863
2-methylvalericacid
22160-39-0
n-c3h7ch(ch3)cooh
W-100103
mfcd00002671
(2rs)-2-methylpentanoic acid
(+/-)-2-methylvaleric acid
(+/-)-2-methylpentanoic acid
D78086
Q27254086
SB47595
EN300-20163
CS-W011232
HY-W010516
PD144384
Z104477112
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (3)

RoleDescription
flavouring agentA food additive that is used to added improve the taste or odour of a food.
plant metaboliteAny eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
fragranceA substance, extract, or preparation for diffusing or imparting an agreeable or attractive smell.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (4)

ClassDescription
branched-chain saturated fatty acidAny saturated fatty acid with a carbon side-chain or isopropyl termination.
methyl-branched fatty acidAny branched-chain fatty acid containing methyl branches only.
monocarboxylic acidAn oxoacid containing a single carboxy group.
short-chain fatty acidAn aliphatic monocarboxylic acid with a chain length of less than C6. If any non-hydrocarbon substituent is present, the compound is not normally regarded as a short-chain fatty acid.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (5)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
AR proteinHomo sapiens (human)Potency29.66740.000221.22318,912.5098AID743035
estrogen receptor 2 (ER beta)Homo sapiens (human)Potency55.46320.000657.913322,387.1992AID1259377; AID1259378
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency22.06430.003041.611522,387.1992AID1159552; AID1159555
retinoid X nuclear receptor alphaHomo sapiens (human)Potency18.71890.000817.505159.3239AID1159527
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency52.27400.001530.607315,848.9004AID1224841; AID1224842; AID1224848; AID1224849
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID1750491Reduction of propionyl-CoA in human hepatocytes derived from propionic acidemia patient at 100 uM pretreated for 30 mins followed by 13C-isoleucine addition and measured after 1 hr by MS/MS analysis relative to control2021Journal of medicinal chemistry, 04-22, Volume: 64, Issue:8
Identification of 2,2-Dimethylbutanoic Acid (HST5040), a Clinical Development Candidate for the Treatment of Propionic Acidemia and Methylmalonic Acidemia.
AID1750492Reduction of propionyl-CoA in human hepatocytes derived from propionic acidemia patient pretreated for 30 mins followed by 13C-isoleucine addition and measured after 1 hr by MS/MS analysis2021Journal of medicinal chemistry, 04-22, Volume: 64, Issue:8
Identification of 2,2-Dimethylbutanoic Acid (HST5040), a Clinical Development Candidate for the Treatment of Propionic Acidemia and Methylmalonic Acidemia.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (11)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (18.18)18.7374
1990's2 (18.18)18.2507
2000's0 (0.00)29.6817
2010's6 (54.55)24.3611
2020's1 (9.09)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 47.37

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index47.37 (24.57)
Research Supply Index2.48 (2.92)
Research Growth Index5.20 (4.65)
Search Engine Demand Index67.14 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (47.37)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (9.09%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other10 (90.91%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]